Table 2 Summary of tablet acceptance for dogs administered Credelio Plus or Nexgard Spectra tablets in the safety population
| Treatment group | Number of dogs | Number of dogs consuming tabletfree choice (%) | Number of dogs manually dosed (pilled) (%) |
|---|---|---|---|
| Credelio Plus | 355 | 292 (82.3%) | 63 (17.7%) |
| Nexgard Spectra | 151 | 122 (80.8%) | 29 (19.2%) |